Cargando…
THU552 Understanding Radiation Therapy Sensitivity In Invasive Lobular Carcinoma Of The Breast
Disclosure: M.R. Boysen: None. M.J. Sikora: None. M. Shackleford: None. J. Sottnik: None. Invasive lobular carcinoma of the breast (ILC) affects ∼40,000 US women annually and is a top-ten most common cancer affecting women. Despite most ILC having biomarkers of “low risk” disease (e.g. ∼95% are estr...
Autores principales: | Boysen, Michael Rhinehart, Sikora, Matthew Joseph, Shackleford, Madeleine, Sottnik, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554333/ http://dx.doi.org/10.1210/jendso/bvad114.2178 |
Ejemplares similares
-
THU477 Drivers Of Estrogen Induced Invasive Lobular Carcinoma
por: Ufondu, Chinasa, et al.
Publicado: (2023) -
THU495 Glutamate Metabolic Enzymes GLUD1/2 And GPX4 Are Associated with Tumor Size In Black Women With Invasive Lobular Breast Cancer
por: Young, Todd, et al.
Publicado: (2023) -
Estrogen Regulation of mTOR Signaling and Mitochondrial Function in Invasive Lobular Carcinoma Cell Lines Requires WNT4
por: Shackleford, Madeleine T., et al.
Publicado: (2020) -
OR16-01 A Common WNT4 Polymorphism Drives Gynecologic Cancer Phenotypes And Health Disparities
por: Bitler, Benjamin G, et al.
Publicado: (2023) -
OR07-2 Endocrine Response And Resistance Is Driven By Novel Transcriptional Co-Regulator Activity In Invasive Lobular Carcinoma Of The Breast
por: Costello, James, et al.
Publicado: (2022)